SCHEMBL31345969

SCHEMBL31345969

FC(F)(F)c1cc(Cl)c2c(c1)CC(c1cccc(-c3nnn[nH]3)n1)O2

nearest known ligand 0.32

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
CBFB Q13951 1/20 0.32
TNF P01375 1/20 0.30
IL1B P01584 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31346094 0.83 BACE1 (0.32)
SCHEMBL31346092 0.83 BACE1 (0.32)
SCHEMBL31346044 0.82 MRGPRX4 (0.31)
SCHEMBL31346083 0.79 TEAD1 (0.33) CBFB
SCHEMBL31346145 0.79 TEAD1 (0.33) CBFB
SCHEMBL31346168 0.78
SCHEMBL31346027 0.77
SCHEMBL31346003 0.76 CTSS (0.42)
SCHEMBL31346165 0.68 EZH2 (0.33)
SCHEMBL31345985 0.68 TEAD1 (0.37)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4712967-A2 G-PROTEIN COUPLED RECEPTOR ANTAGONIST Enveda Therapeutics, Inc. (US) 2026-03-25 EP disclosed
WO-2024239000-A2 G-PROTEIN COUPLED RECEPTOR ANTAGONIST ENVEDA THERAPEUTICS, INC. (US) 2024-11-21 WO disclosed